| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Thrombectomy | $203.5M | $204.14M | $220.13M | $226.54M | $230.26M | $236.42M | $254.7M | $253.92M |
| Embolization and Access | $95.9M | $96.9M | — | $97.6M | $109.2M | $118.26M | — | $120.84M |
| Embolization and Other | $94.79M | $94.79M | $94.79M | $113.94M | $113.94M | $113.94M | $113.94M | — |
| Total | $299.4M | $301.04M | $315.52M | $324.14M | $339.46M | $354.69M | $385.39M | $374.76M |
Embolization and Other is derived from annual filings.